Wuppertal, Germany

Klaus-Peter Voges

This inventor holds 3 USPTO granted patents. Top assignees: Bayer Aktiengesellschaft, Bayer Yakuhin, Ltd., Other. Active years: 1992-2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Leverkusen, DE (1992)
  • Wuppertal, DE (1992 - 2002)

Company Filing History:


Years Active: 1992-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Klaus-Peter Voges: Innovator in Pharmaceutical Chemistry

Introduction

Klaus-Peter Voges is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new compounds with therapeutic applications. With a total of 3 patents to his name, Voges has demonstrated a commitment to innovation in drug development.

Latest Patents

One of his latest patents is focused on a thermodynamically stable form of (R)-3-[[[4-fluorophenyl] sulphonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid, commonly known as ramatroban. This invention relates to a stable modification of ramatroban, which can be prepared through melting and recrystallization or by seeding a solution with a seed crystal of the stable form. This stable compound has potential applications as an asthma agent. Another significant patent involves the development of antiviral new peptides, which are designed to combat viral infections.

Career Highlights

Throughout his career, Klaus-Peter Voges has worked with prominent companies, including Bayer Aktiengesellschaft. His work has contributed to advancements in pharmaceutical formulations and therapeutic agents.

Collaborations

Voges has collaborated with notable colleagues such as Arnold Paessens and Jutta Hansen, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Klaus-Peter Voges is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…